Study reveals correlation between number of patients and phase of oncology clinical trials

A recent study, “Oncology Clinical Trials: Drug Development and Case Studies” examined the average number of patients per site during different phases of oncology trials. The study found that Phase 1 trials averaged 12.9 patients per site, while Phase 2 and Phase trials averaged 3.4 and 5.1 patients per site respectively.  Additionally, Phase 1 trials had higher patient enrollment per trial site, whereas Phase 2 and 3 trials had more sites with fewer patients. The findings can potentially help trial managers plan oncology related trials. To read more about the study, click here for a recent article on buisnesswire.com. If you need help with an upcoming clinical trial, contact us at 317-899-9341.